Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
West Virginia University
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Tessa Therapeutics
Fred Hutchinson Cancer Center
Thomas Jefferson University
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Texas Southwestern Medical Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
Northside Hospital, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
University of Chicago
National Cancer Institute (NCI)
Northside Hospital, Inc.
Northside Hospital, Inc.
National Cancer Institute (NCI)